C07D 489/04
Salts
Official title: Salts; Organic complexes
C07D489/04 (Salts) appears on 103 US grants and 140 published applications in this corpus.
Search patents in C07D- Granted patents
- 103
- Published applications
- 140
- Assignees
- 50
- Inventors
- 193
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 0 |
| 2003 | 0 | 1 |
| 2004 | 2 | 2 |
| 2005 | 0 | 3 |
| 2006 | 3 | 3 |
| 2007 | 0 | 8 |
| 2008 | 0 | 2 |
| 2009 | 1 | 7 |
| 2010 | 5 | 10 |
| 2011 | 0 | 7 |
| 2012 | 6 | 6 |
| 2013 | 9 | 6 |
| 2014 | 10 | 4 |
| 2015 | 12 | 15 |
| 2016 | 5 | 24 |
| 2017 | 10 | 7 |
| 2018 | 7 | 10 |
| 2019 | 8 | 6 |
| 2020 | 7 | 3 |
| 2021 | 1 | 3 |
| 2022 | 3 | 2 |
| 2023 | 2 | 5 |
| 2024 | 2 | 2 |
| 2025 | 0 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Long-acting injectable formulations and crystalline forms of buprenorphine derivatives13 Jan 2026US 12,522,610 B2Alar Pharmaceuticals Inc.
- Solid forms of Alpha-1062 gluconate3 Dec 2024US 12,157,743 B2Alpha Cognition Inc.
- Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone13 Aug 2024US 12,060,361 B2Purdue Pharma L. P.
- Solid forms of Alpha-1062 gluconate24 Oct 2023US 11,795,176 B2Alpha Cognition Inc.
- 6-acetylmorphine analogs, and methods for their synthesis and use18 Apr 2023US 11,628,216 B2Alere San Diego, Inc.
- Long-acting injectable formulations and crystalline forms of buprenorphine derivatives6 Aug 2026US 2026/0226072 A1Alar Pharmaceuticals Inc.
- Improved synthesis of buprenorphine, analogues and intermediates30 Jul 2026US 2026/0217726 A1
- Amorphous solid forms of alpha-1062 gluconate16 Oct 2025US 2025/0320223 A1Alpha Cognition Inc.
- Solid forms of alpha-1062 gluconate20 Mar 2025US 2025/0092055 A1Alpha Cognition Inc.
- Synergistic cannabinoid esters, their salts and uses thereof13 Jun 2024US 2024/0189327 A1London Pharmaceuticals and Research Corporation
Most cited
By later US patents
- Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone147US 7,683,072 B2Purdue Pharma L. P. · 2010
- Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone142US 7,674,799 B2Purdue Pharma L. P. · 2010
- Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone140US 7,674,800 B2Purdue Pharma L. P. · 2010
- Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone128US 7,129,248 B2Euro-Celtique S. A. · 2006
- Preparation of oxycodone74US 7,153,966 B2Johnson Matthey Public Limited Company · 2006